湿疹治療薬市場は2023年から2028年に58億1,000万米ドル、予測期間中のCAGRは10.28%で成長すると予測されます。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。
このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。市場は、アトピー性皮膚炎の有病率の高さ、湿疹治療のための製品上市の増加、エンドユーザーにおける市販（OTC）湿疹治療薬の需要増加が牽引しています。
本調査では、湿疹治療薬における遠隔医療プラットフォームの採用が増加していることが、今後数年間の湿疹治療薬市場成長を牽引する主要因の1つであると分析しています。また、湿疹治療への生物学的療法の採用拡大や、湿疹治療薬の需要を急増させるヘルスケア支出の増加も、市場の大きな需要につながります。
また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。
この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。
このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。
目次
Table of Contents
1 Executive Summary
1.1 Market overview
2 Market Landscape
2.1 Market ecosystem
3 Market Sizing
3.1 Market definition
3.2 Market segment analysis
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
4 Historic Market Size
4.1 Global eczema therapeutics market 2018 - 2022
4.2 Application Segment Analysis 2018 - 2022
4.3 Distribution channel Segment Analysis 2018 - 2022
4.4 Geography Segment Analysis 2018 - 2022
4.5 Country Segment Analysis 2018 - 2022
5 Five Forces Analysis
5.1 Five forces summary
5.2 Bargaining power of buyers
5.3 Bargaining power of suppliers
5.4 Threat of new entrants
5.5 Threat of substitutes
5.6 Threat of rivalry
5.7 Market condition
6 Market Segmentation by Application
6.1 Market segments
6.2 Comparison by Application
6.3 Atopic dermatitis - Market size and forecast 2023-2028
6.4 Contact dermatitis - Market size and forecast 2023-2028
6.5 Other indication - Market size and forecast 2023-2028
6.6 Market opportunity by Application
7 Market Segmentation by Distribution Channel
7.1 Market segments
7.2 Comparison by Distribution Channel
7.3 Hospital and clinics - Market size and forecast 2023-2028
7.4 Online pharmacies - Market size and forecast 2023-2028
7.5 Retail pharmacies - Market size and forecast 2023-2028
7.6 Market opportunity by Distribution Channel
8 Customer Landscape
8.1 Customer landscape overview
9 Geographic Landscape
9.1 Geographic segmentation
9.2 Geographic comparison
9.3 North America - Market size and forecast 2023-2028
9.4 Europe - Market size and forecast 2023-2028
9.5 Asia - Market size and forecast 2023-2028
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
9.7 US - Market size and forecast 2023-2028
9.8 Germany - Market size and forecast 2023-2028
9.9 UK - Market size and forecast 2023-2028
9.10 China - Market size and forecast 2023-2028
9.11 Canada - Market size and forecast 2023-2028
9.12 Market opportunity By Geographical Landscape
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
11.3 Landscape disruption
11.4 Industry risks
12 Vendor Analysis
12.1 Vendors covered
12.2 Market positioning of vendors
12.3 AbbVie Inc.
12.4 Alliance Pharma PLC
12.5 Amneal Pharmaceuticals Inc.
12.6 AstraZeneca PLC
12.7 Bausch Health Companies Inc.
12.8 Bayer AG
12.9 Cadila Pharmaceuticals Ltd.
12.10 Eli Lilly and Co.
12.11 LEO Pharma AS
12.12 Lupin Ltd.
12.13 Merck and Co. Inc.
12.14 Novartis AG
12.15 Pfizer Inc.
12.16 Sanofi SA
12.17 Viatris Inc.
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
13.3 Currency conversion rates for US$
13.4 Research methodology
13.5 List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global eczema therapeutics market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Application Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Distribution channel Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Application - Market share 2023-2028 (%)
Exhibits31: Data Table on Application - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Atopic dermatitis - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Atopic dermatitis - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Atopic dermatitis - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Atopic dermatitis - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Contact dermatitis - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Contact dermatitis - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Contact dermatitis - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Contact dermatitis - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Other indication - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Other indication - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Other indication - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Other indication - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Application ($ billion)
Exhibits47: Data Table on Market opportunity by Application ($ billion)
Exhibits48: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits49: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by Distribution Channel
Exhibits51: Data Table on Comparison by Distribution Channel
Exhibits52: Chart on Hospital and clinics - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Hospital and clinics - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Hospital and clinics - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Hospital and clinics - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits61: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ billion)
Exhibits62: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)
Exhibits64: Market opportunity by Distribution Channel ($ billion)
Exhibits65: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits104: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits105: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ billion)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits109: Impact of drivers and challenges in 2023 and 2028
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: AbbVie Inc. - Overview
Exhibits116: AbbVie Inc. - Product / Service
Exhibits117: AbbVie Inc. - Key news
Exhibits118: AbbVie Inc. - Key offerings
Exhibits119: Alliance Pharma PLC - Overview
Exhibits120: Alliance Pharma PLC - Business segments
Exhibits121: Alliance Pharma PLC - Key offerings
Exhibits122: Alliance Pharma PLC - Segment focus
Exhibits123: Amneal Pharmaceuticals Inc. - Overview
Exhibits124: Amneal Pharmaceuticals Inc. - Business segments
Exhibits125: Amneal Pharmaceuticals Inc. - Key news
Exhibits126: Amneal Pharmaceuticals Inc. - Key offerings
Exhibits127: Amneal Pharmaceuticals Inc. - Segment focus
Exhibits128: AstraZeneca PLC - Overview
Exhibits129: AstraZeneca PLC - Product / Service
Exhibits130: AstraZeneca PLC - Key news
Exhibits131: AstraZeneca PLC - Key offerings
Exhibits132: Bausch Health Companies Inc. - Overview
Exhibits133: Bausch Health Companies Inc. - Business segments
Exhibits134: Bausch Health Companies Inc. - Key news
Exhibits135: Bausch Health Companies Inc. - Key offerings
Exhibits136: Bausch Health Companies Inc. - Segment focus
Exhibits137: Bayer AG - Overview
Exhibits138: Bayer AG - Business segments
Exhibits139: Bayer AG - Key news
Exhibits140: Bayer AG - Key offerings
Exhibits141: Bayer AG - Segment focus
Exhibits142: Cadila Pharmaceuticals Ltd. - Overview
Exhibits143: Cadila Pharmaceuticals Ltd. - Product / Service
Exhibits144: Cadila Pharmaceuticals Ltd. - Key news
Exhibits145: Cadila Pharmaceuticals Ltd. - Key offerings
Exhibits146: Eli Lilly and Co. - Overview
Exhibits147: Eli Lilly and Co. - Product / Service
Exhibits148: Eli Lilly and Co. - Key news
Exhibits149: Eli Lilly and Co. - Key offerings
Exhibits150: LEO Pharma AS - Overview
Exhibits151: LEO Pharma AS - Business segments
Exhibits152: LEO Pharma AS - Key offerings
Exhibits153: LEO Pharma AS - Segment focus
Exhibits154: Lupin Ltd. - Overview
Exhibits155: Lupin Ltd. - Product / Service
Exhibits156: Lupin Ltd. - Key news
Exhibits157: Lupin Ltd. - Key offerings
Exhibits158: Merck and Co. Inc. - Overview
Exhibits159: Merck and Co. Inc. - Business segments
Exhibits160: Merck and Co. Inc. - Key news
Exhibits161: Merck and Co. Inc. - Key offerings
Exhibits162: Merck and Co. Inc. - Segment focus
Exhibits163: Novartis AG - Overview
Exhibits164: Novartis AG - Business segments
Exhibits165: Novartis AG - Key news
Exhibits166: Novartis AG - Key offerings
Exhibits167: Novartis AG - Segment focus
Exhibits168: Pfizer Inc. - Overview
Exhibits169: Pfizer Inc. - Product / Service
Exhibits170: Pfizer Inc. - Key news
Exhibits171: Pfizer Inc. - Key offerings
Exhibits172: Sanofi SA - Overview
Exhibits173: Sanofi SA - Business segments
Exhibits174: Sanofi SA - Key news
Exhibits175: Sanofi SA - Key offerings
Exhibits176: Sanofi SA - Segment focus
Exhibits177: Viatris Inc. - Overview
Exhibits178: Viatris Inc. - Business segments
Exhibits179: Viatris Inc. - Key news
Exhibits180: Viatris Inc. - Key offerings
Exhibits181: Viatris Inc. - Segment focus
Exhibits182: Inclusions checklist
Exhibits183: Exclusions checklist
Exhibits184: Currency conversion rates for US$
Exhibits185: Research methodology
Exhibits186: Validation techniques employed for market sizing
Exhibits187: Information sources
Exhibits188: List of abbreviations
